IL-17A disrupts the nasal mucosal epithelial barrier in patients with chronic rhinosinusitis by activating the ERK/STAT3 pathway
IL-17A disrupts the nasal mucosal epithelial barrier by activating the ERK/STAT3 pathway in patients with CRS.
Authors
- Chang Li (ORCID: https://orcid.org/0000-0002-3267-1859)
- Xing Lai (ORCID: https://orcid.org/0000-0002-2543-816X)
- Yue Li (ORCID: https://orcid.org/0009-0008-0483-4789)
- Ze-Ning Huang (ORCID: https://orcid.org/0000-0001-7284-3689)
- Gan‐Lin Zhang (ORCID: https://orcid.org/0000-0002-6189-5018)
- Jun Ma (ORCID: https://orcid.org/0000-0002-1137-9349)
- Liang Yu (ORCID: https://orcid.org/0009-0007-3922-3454)
- X Li
- Weicai Huang
- H. Wu
Institutions
- Sun Yat-sen University (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
Publication Details
- Journal
- Rhinology Journal
- Published
- 2024-10-01
- DOI
- https://doi.org/10.4193/rhin24.127
- Citations
- 5
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 2.90